drugset / Trial / NCT00971802
A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers
RandomizedParallel-groupDouble-blind
Summary
To evaluate the safety and tolerability of PF-03882845 in Healthy Volunteers. To evaluate the pharmacokinetics of PF-03882845 in Healthy Volunteers. To evaluate the pharmacodynamics of PF-03882845 in Healthy Volunteers.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03882845 | Small molecule | 20 mg | Oral |
| Subject | PF-03882845 | Small molecule | 60 mg | Oral |
| Subject | PF-03882845 | Small molecule | 120 mg | Oral |
| Subject | PF-03882845 | Small molecule | 185 mg | Oral |
Indications
No indication recorded.